Plasminogen activator inhibitor-1 activity and long-term outcome in patients with ST-elevation myocardial infarction

Marin Pavlov1, Vjeran Nikolić-Heitzler, Zdravko Babić

  • 1Marin Pavlov, Department of Cardiology, Sestre Milosrdnice University Hospital Center, Vinogradska cesta 29, 10000 Zagreb, Croatia, marin.pavlov@gmail.com.

Insights

A significant rise in plasminogen activator inhibitor-1 (PAI-1) activity during ST-elevation myocardial infarction (STEMI) treatment predicts a higher risk of death within five years. This finding aids in stratifying mortality risk for STEMI patients undergoing primary PCI.

Area of Science:

  • Cardiology
  • Biomarkers
  • Clinical Research

Background:

  • ST-elevation myocardial infarction (STEMI) is a critical cardiovascular event.
  • Early identification of patients at high risk for long-term mortality is crucial for effective treatment strategies.
  • Plasminogen activator inhibitor-1 (PAI-1) is a key regulator of fibrinolysis and has been implicated in cardiovascular disease.

Purpose of the Study:

  • To investigate the association between the change in plasminogen activator inhibitor-1 (PAI-1) activity within 24 hours of STEMI treatment and 5-year mortality.
  • To evaluate PAI-1 activity rise as a potential prognostic biomarker in STEMI patients treated with primary percutaneous coronary intervention (PCI).

Main Methods:

  • A prospective cohort study enrolled 87 STEMI patients treated with primary PCI.
  • PAI-1 activity was measured on admission and 24 hours post-treatment.
  • Statistical analyses included ROC curves for predictive value, Cox regression for independent predictors, and linear regression for related covariates.

Main Results:

  • PAI-1 activity rise demonstrated strong predictive value for 5-year mortality (AUC=0.748, optimal cut-off 3.7 U/mL).
  • Patients with PAI-1 activity rise >3.7 U/mL exhibited significantly higher mortality (P<0.001).
  • Independent predictors of death included PAI-1 rise and final Thrombolysis in Myocardial Infarction (TIMI) flow; PAI-1 rise correlated with heart failure, thrombus aspiration, and body weight.

Conclusions:

  • An elevated PAI-1 activity rise (>3.7 U/mL) within 24 hours of primary PCI for STEMI is significantly associated with increased 5-year mortality.
  • PAI-1 activity rise serves as a valuable prognostic marker in STEMI patients.
  • Further research may explore therapeutic targeting of PAI-1 in STEMI management.
Abstract

Related Concept Videos

Primary Active Transport01:47

Primary Active Transport

In contrast to passive transport, active transport involves a substance being moved through membranes in a direction against its concentration or electrochemical gradient. There are two types of active transport: primary active transport and secondary active transport. Primary active transport utilizes chemical energy from ATP to drive protein pumps that are embedded in the cell membrane. With energy from ATP, the pumps transport ions against their electrochemical gradients—a direction...
199.4K
Primary Active Transport01:29

Primary Active Transport

In contrast to passive transport, active transport involves a substance being moved through membranes in a direction against its concentration or electrochemical gradient. There are two types of active transport: primary active transport and secondary active transport. Primary active transport utilizes chemical energy from ATP to drive protein pumps embedded in the cell membrane. With energy from ATP, the pumps transport ions against their electrochemical gradients—a direction they would...
14.4K
Secondary Active Transport01:55

Secondary Active Transport

One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
138.1K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.7K
tRNA Activation02:26

tRNA Activation

Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
23.0K
Activation Energy01:26

Activation Energy

Activation energy is the minimum amount of energy necessary for a chemical reaction to move forward. The higher the activation energy, the slower the rate of the reaction. However, adding heat to the reaction will increase the rate, since it causes molecules to move faster and increase the likelihood that molecules will collide. The collision and breaking of bonds represents the uphill phase of a reaction and generates the transition state. The transition state is an unstable high-energy state...
86.8K